Browsing by Subject "BCG"
Now showing items 1-5 of 5
-
Comparative study of RT23 and Merieux tuberculin tested among healthy volunteers
(2009)SETTING: Several studies have indicated considerable variability in the biological results of different tuberculin preparations in different geographical areas or even within a single region. OBJECTIVE: To compare the ... -
In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG)
(2006)Background: Mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) intravesical instillations are widely and effectively used as adjuvant treatment for superficial bladder cancer. In an attempt to improve the efficacy of ... -
Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy
(2009)We conducted a prospective study to determine whether expression of telomerase reverse transcriptase (hTERT) is associated with recurrence-free-survival (RFS) or development of invasive disease in patients with high risk ... -
Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG
(2014)We conducted a retrospective study to determine the prognostic significance of age, gender, associated carcinoma in situ, stage, number of tumors, and tumor size for patients with high-risk non-muscle-invasive bladder ...